[Ocular retention in patients with uveal melanoma managed by a multimodality approach]

Arch Soc Esp Oftalmol. 2009 Mar;84(3):145-9. doi: 10.4321/s0365-66912009000300007.
[Article in Spanish]

Abstract

Objective: to analyze ocular survival in eyes with uveal melanoma treated with conservative therapies, in a centre that applies all treatment modalities.

Methods: Patients diagnosed with uveal melanoma and treated between September 1990 and April 2007 were included in an historical cohorts study.

Results: 273 patients were included. 193 were treated with conservative treatments (70.69%) and 80 were enucleated as primary treatment. 14 patients were enucleated after conservative treatment (7.2%). Kaplan-Meier survival analysis showed an 88% survival probability of the eye in the first 5 years after conservative treatment and 83% at 10 years.

Conclusions: Conservative treatments for uveal melanoma, especially brachitherapy, are safe and effective in relation to tumor control and rate of secondary effects.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Brachytherapy
  • Cohort Studies
  • Combined Modality Therapy
  • Eye Enucleation
  • Female
  • Follow-Up Studies
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Melanoma / diagnosis
  • Melanoma / mortality
  • Melanoma / radiotherapy
  • Melanoma / surgery
  • Melanoma / therapy*
  • Middle Aged
  • Time Factors
  • Uveal Neoplasms / diagnosis
  • Uveal Neoplasms / mortality
  • Uveal Neoplasms / radiotherapy
  • Uveal Neoplasms / surgery
  • Uveal Neoplasms / therapy*